Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
18 November 2024Antibiotic resistant infections continue to rise
Antibiotic resistant infections have surpassed pre-pandemic levels in 2023, with an estimated 66,730 serious infections compared to 62,314 in 2019. The majority of these infections (65%) were caused by E. coli, a common cause of urinary tract infections, diarrhoea, vomiting, and fever. These bacteria are less likely to respond to treatment, causing serious complications and […]
Read more... -
15 November 2024The multifaceted nature of lack of access to antibiotics: types of shortage and specific causes, consequences, and solutions
This paper discusses the challenges of maintaining access to antibiotics due to supply, market, and demand issues. It identifies four types of lack of access: short-term shortages, long-term shortages, deregistrations, and lack of registration. Common causes include unattractive markets, dependence on few suppliers, and insufficient communication. Longer shortages have more serious clinical consequences and higher […]
Read more... -
08 November 2024Patterns of antibiotic resistance genes and virulence factor genes in the gut microbiome of patients with osteoarthritis and rheumatoid arthritis
The gut microbiome compositions of Osteoarthritis (OA) and Rheumatoid Arthritis (RA) patients have been studied, but functional genomics, specifically ARGs and VFGs, have not been explored. A study using gut metagenomic data found that both OA and RA patients have higher alpha diversity in ARGs compared to healthy controls. VFGs showed higher diversity in RA, […]
Read more...
More news related to Healthy patients